about
Advances in understanding itching and scratching: a new era of targeted treatmentsPharmacological interventions for pruritus in adult palliative care patients.Generation of a KOR-Cre knockin mouse strain to study cells involved in kappa opioid signalingPruritus: an overview. What drives people to scratch an itch?Therapeutic Effects of Omega-3 Fatty Acids on Chronic Kidney Disease-Associated Pruritus: a Literature Review.Seeking (and Finding) Biased Ligands of the Kappa Opioid Receptor.New and Emerging Targeted Systemic Therapies: A New Era for Atopic Dermatitis.Advances in therapeutic strategies for the treatment of pruritus.Chronic Pruritus in the Absence of Skin Disease: Pathophysiology, Diagnosis and Treatment.Chronic kidney disease-associated pruritus: impact on quality of life and current management challenges.Chronic Pruritus: Current and Emerging Treatment Options.In Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse Potential.Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats.Effects of ICI204,448, naloxone methiodide and levocetirizine on the scratching behavior induced by a κ-opioid antagonist, nor-BNI, in ICR mice.Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain/itch-stimulated and pain/itch-depressed behaviors in male rats.Diagnosis and treatment of pruritus.Diagnostic et traitement du prurit.Natural product modulators of human sensations and mood: molecular mechanisms and therapeutic potential.Opioids and skin homeostasis, regeneration and ageing - What's the evidence?
P2860
Q28071549-821564BD-D266-45A3-AF37-DDFFD405B7C1Q36193800-8A94BD3E-803E-4575-9787-EBD1ECD009F1Q36561843-E3F8DCFA-D4D8-49DC-91D4-4F1066B02855Q37272308-406F7551-332C-4AA6-BC87-835A703F503AQ37590722-A13BD68F-65C7-4B79-823D-8A73FA0134C6Q38429628-CE693D8E-85A6-4B99-B684-7ED093A469E0Q38602326-9A34F743-A373-40A8-AAA7-1652650F9905Q38656850-EAC82891-9C48-4DA9-B715-88EF1D574C93Q38842371-C1C142D3-4912-4F3D-ADE2-9BBB37435E16Q39125911-3578F49E-471E-4405-8D03-9998350437D1Q39156148-D85FFAC2-F883-4F1C-A2A8-F5C83712A843Q42067858-2E106ED4-FDE4-4C23-B45E-7BEABDF3F5AAQ44346108-88D548E1-690B-4FA2-8A4F-7FF5DE39A4B9Q44347577-FBAFD314-89A1-4FB2-9067-7B2EE6886561Q44350143-93F7DC72-A4B4-4A56-807A-DE51AD171071Q47115833-FFCED138-F059-43CB-972B-496E89B1D056Q47125066-06CA281F-4E71-410F-A86A-C4E446EECF9AQ47652702-722F0799-02C9-4E6E-A6AC-16113CEC4ABFQ52876035-AD04A82F-D13E-433B-986F-B88EE251F709
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Nalfurafine hydrochloride to treat pruritus: a review.
@en
type
label
Nalfurafine hydrochloride to treat pruritus: a review.
@en
prefLabel
Nalfurafine hydrochloride to treat pruritus: a review.
@en
P2860
P356
P1476
Nalfurafine hydrochloride to treat pruritus: a review.
@en
P2093
Shigeki Inui
P2860
P304
P356
10.2147/CCID.S55942
P407
P577
2015-05-11T00:00:00Z